PubRank

Andreas Buck

Author PubWeight™ 30.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007 6.65
2 Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 2005 3.18
3 Positron detection for the intraoperative localisation of cancer deposits. Eur J Nucl Med Mol Imaging 2007 1.95
4 Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood 2010 1.76
5 Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors. Arch Orthop Trauma Surg 2009 1.49
6 3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease. Cancer Res 2003 1.21
7 Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT. Eur J Nucl Med Mol Imaging 2008 1.17
8 Prospective evaluation of factors influencing success rates of sentinel node biopsy in 814 breast cancer patients. Cancer Biother Radiopharm 2004 1.10
9 Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer. J Oncol 2009 1.06
10 Structured treatment interruption in patients with alveolar echinococcosis. Hepatology 2004 1.02
11 FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy. Cancer Res 2012 0.95
12 Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells. Cancer Gene Ther 2003 0.92
13 Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob Agents Chemother 2003 0.91
14 Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice. Atherosclerosis 2013 0.89
15 Conformational restriction via cyclization in beta-amyloid peptide Abeta(1-28) leads to an inhibitor of Abeta(1-28) amyloidogenesis and cytotoxicity. Chem Biol 2003 0.86
16 Antifungal therapy with itraconazole impairs the anti-lymphoma effects of rituximab by inhibiting recruitment of CD20 to cell surface lipid rafts. Cancer Res 2010 0.83
17 Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities. Cancer Biother Radiopharm 2002 0.83
18 Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy. Cancer Biother Radiopharm 2003 0.81
19 The lymphoma-like polychemotherapy regimen "Dexa-BEAM" in advanced and extramedullary multiple myeloma. Ann Hematol 2014 0.79
20 Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer. Eur J Nucl Med Mol Imaging 2004 0.78
21 Focal uptake of 68Ga-DOTATOC in the pancreas: pathological or physiological correlate in patients with neuroendocrine tumours? Eur J Nucl Med Mol Imaging 2011 0.76
22 Melanoma metastases to palatine tonsils obscured by physiological FDG uptake on PET/CT. Clin Nucl Med 2010 0.75
23 Staging of non-small-cell lung cancer with integrated PET and CT. N Engl J Med 2003 0.75
24 Demonstration of metastatic tumour growth following vessel structures by PET/CT. Eur J Nucl Med Mol Imaging 2009 0.75